Browse studies

Find your next paid study

1 recruiting study matching your filters

A Randomized, Double-Blind, Placebo-Controlled, Delayed-Start Study to Evaluate the Efficacy and Safety of Exaluren in Alport Syndrome Patients With Nonsense Mutations in COL4A3/4/5 Genes

This is a randomized, double-Blind, placebo-controlled study to evaluate the efficacy and safety of exaluren in Alport Syndrome patients with nonsense mutation…

Alport Syndrome, X-LinkedAlport Syndrome, Autosomal Recessive

Eloxx Pharmaceuticals, Inc.NCT07523581